US7205307B2
(en)
*
|
2002-02-14 |
2007-04-17 |
Icagen, Inc. |
Pyrimidines as novel openers of potassium ion channels
|
MXPA05000200A
(es)
|
2002-07-02 |
2005-06-06 |
Schering Corp |
Nuevos antagonistas del receptor neuropeptido y y5.
|
US7186735B2
(en)
*
|
2002-08-07 |
2007-03-06 |
Sanofi-Aventis Deutschland Gmbh |
Acylated arylcycloalkylamines and their use as pharmaceuticals
|
EP1388535A1
(de)
*
|
2002-08-07 |
2004-02-11 |
Aventis Pharma Deutschland GmbH |
Acylierte Arylcycloalkylamine und ihre Anwendung als Arzneimittelwirkstoff
|
GB0219961D0
(en)
*
|
2002-08-28 |
2002-10-02 |
Pfizer Ltd |
Oxytocin inhibitors
|
AU2003295041A1
(en)
*
|
2002-11-20 |
2004-06-18 |
L'oreal |
Composition for hair care or eyelashes containing a pyrazol-carboxamide, its use for stimulating hair and eyelash growth and/or for preventing loss thereof
|
CA2515119A1
(en)
|
2003-02-07 |
2004-08-19 |
Daiichi Pharmaceutical Co., Ltd. |
Pyrazole derivative
|
US7531558B2
(en)
*
|
2003-02-14 |
2009-05-12 |
Glaxo Group Limited |
Carboxamide derivatives
|
SE0300705D0
(sv)
*
|
2003-03-14 |
2003-03-14 |
Biolipox Ab |
New compounds
|
ATE467616T1
(de)
*
|
2003-04-11 |
2010-05-15 |
High Point Pharmaceuticals Llc |
Verbindungen mit aktivität an der 11beta- hydroxasteroiddehydrogenase
|
AR045979A1
(es)
*
|
2003-04-28 |
2005-11-23 |
Astrazeneca Ab |
Amidas heterociclicas
|
US20040220170A1
(en)
*
|
2003-05-01 |
2004-11-04 |
Atkinson Robert N. |
Pyrazole-amides and sulfonamides as sodium channel modulators
|
RU2342365C2
(ru)
*
|
2003-05-01 |
2008-12-27 |
Бристол-Маерс Сквибб Компани |
Арилзамещенные пиразоламиды в качестве ингибиторов киназ
|
WO2004108133A2
(en)
*
|
2003-06-05 |
2004-12-16 |
Vertex Pharmaceuticals Incorporated |
Modulators of vr1 receptor
|
WO2005030128A2
(en)
*
|
2003-09-23 |
2005-04-07 |
Merck & Co., Inc. |
Pyrazole modulators of metabotropic glutamate receptors
|
DE10360369A1
(de)
*
|
2003-12-22 |
2005-07-14 |
Bayer Cropscience Ag |
Amide
|
CN101018779A
(zh)
*
|
2004-02-18 |
2007-08-15 |
阿斯利康(瑞典)有限公司 |
三唑化合物及其作为代谢型谷氨酸受体拮抗剂的应用
|
EP1735284A1
(de)
|
2004-03-18 |
2006-12-27 |
Pfizer Limited |
N-(1-arylpyrazol-4l)sulfonamide und deren verwendung als parasitizide
|
PL1789390T3
(pl)
*
|
2004-09-02 |
2012-04-30 |
Genentech Inc |
Pirydylowe inhibitory szlaku sygnałowego hedgehog
|
WO2006032851A1
(en)
|
2004-09-20 |
2006-03-30 |
Biolipox Ab |
Pyrazole compounds useful in the treatment of inflammation
|
WO2006032852A1
(en)
*
|
2004-09-20 |
2006-03-30 |
Biolipox Ab |
Pyrazole compounds useful uin the treatment of inflammation
|
MX2007004403A
(es)
|
2004-10-12 |
2007-04-27 |
Astrazeneca Ab |
Derivados de quinazolina.
|
WO2006089076A2
(en)
|
2005-02-18 |
2006-08-24 |
Neurogen Corporation |
Thiazole amides, imidazole amides and related analogues
|
MY144968A
(en)
|
2005-04-11 |
2011-11-30 |
Xenon Pharmaceuticals Inc |
Spiro-oxindole compounds and their uses as therapeutic agents
|
MY145694A
(en)
|
2005-04-11 |
2012-03-30 |
Xenon Pharmaceuticals Inc |
Spiroheterocyclic compounds and their uses as therapeutic agents
|
WO2006132192A1
(ja)
*
|
2005-06-07 |
2006-12-14 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規2-キノロン誘導体
|
CN1884262B
(zh)
*
|
2005-06-24 |
2014-06-25 |
中国人民解放军军事医学科学院毒物药物研究所 |
4-氨基哌啶类化合物及其医药用途
|
US7615569B2
(en)
*
|
2005-08-16 |
2009-11-10 |
Icagen, Inc. |
Inhibitors of ion channels
|
EP1772449A1
(de)
*
|
2005-10-05 |
2007-04-11 |
Bayer CropScience S.A. |
N-alkyl-heterocyclische carboxamide Derivate
|
WO2007044885A2
(en)
*
|
2005-10-11 |
2007-04-19 |
Chemocentryx, Inc. |
Piperidine derivatives and methods of use
|
TW200800911A
(en)
*
|
2005-10-20 |
2008-01-01 |
Biolipox Ab |
Pyrazoles useful in the treatment of inflammation
|
TW200732320A
(en)
*
|
2005-10-31 |
2007-09-01 |
Biolipox Ab |
Pyrazoles useful in the treatment of inflammation
|
WO2007051982A1
(en)
*
|
2005-10-31 |
2007-05-10 |
Biolipox Ab |
Triazole compounds as lipoxygenase inhibitors
|
WO2007052000A1
(en)
*
|
2005-11-01 |
2007-05-10 |
Biolipox Ab |
Pyrazoles useful in the treatment of inflammation
|
EP1787981A1
(de)
*
|
2005-11-22 |
2007-05-23 |
Bayer CropScience S.A. |
Neue N-phenethylcarboxamidderivate
|
JP2009523748A
(ja)
*
|
2006-01-18 |
2009-06-25 |
シエナ ビオテク ソシエタ ペル アチオニ |
α7ニコチン性アセチルコリン受容体の調節物質およびそれらの治療への使用
|
FR2897061B1
(fr)
*
|
2006-02-03 |
2010-09-03 |
Sanofi Aventis |
Derives de n-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur preparation et leur application en therapeutique.
|
UY30183A1
(es)
|
2006-03-02 |
2007-10-31 |
Astrazeneca Ab |
Derivados de quinolina
|
DK1999114T3
(en)
|
2006-03-22 |
2015-08-03 |
Hoffmann La Roche |
Pyrazoles AS 11-BETA-HSD-1
|
MX2008013194A
(es)
|
2006-04-11 |
2008-12-01 |
Vertex Pharma |
Composiciones utiles como inhibidores de canales de sodio regulados por voltaje.
|
US20110207771A1
(en)
*
|
2006-06-08 |
2011-08-25 |
Syngenta Crop Protection, Inc. |
N-(l-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides
|
EP2041116A1
(de)
|
2006-07-07 |
2009-04-01 |
Boehringer Ingelheim International GmbH |
Phenyl substituierte heteroaryl-derivate und deren verwendung als antitumormittel
|
EP2081905B1
(de)
|
2006-07-28 |
2012-09-12 |
Boehringer Ingelheim International GmbH |
Sulfonyl verbindungen als cb2 rezeptor modulatoren
|
EP2065369A4
(de)
*
|
2006-08-23 |
2011-12-28 |
Astellas Pharma Inc |
Harnstoffverbindung oder salz davon
|
CN101516839A
(zh)
|
2006-09-25 |
2009-08-26 |
贝林格尔.英格海姆国际有限公司 |
调节cb2受体的化合物
|
CA2675511A1
(en)
*
|
2006-10-10 |
2008-04-17 |
Amgen Inc. |
N-aryl pyrazole compounds for use against diabetes
|
WO2008046084A2
(en)
*
|
2006-10-12 |
2008-04-17 |
Xenon Pharmaceuticals Inc. |
Spiroheterocyclic compounds and their uses as therapeutic agents
|
US8466188B2
(en)
|
2006-10-12 |
2013-06-18 |
Xenon Pharmaceuticals Inc. |
Use of spiro-oxindole compounds as therapeutic agents
|
WO2008064054A2
(en)
*
|
2006-11-21 |
2008-05-29 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the cb2 receptor
|
JP2010043004A
(ja)
*
|
2006-12-06 |
2010-02-25 |
Dainippon Sumitomo Pharma Co Ltd |
新規2環性複素環化合物
|
CL2008000512A1
(es)
|
2007-02-22 |
2008-08-29 |
Bayer Cropscience Sa |
Compuestos derivados de n-(3-fenilpropil)carboxamida; procedimiento de preparacion de dichos compuestos; composicion fungicida; y metodo para combatir de forma preventiva o curativa los hongos fitopatogenos de cultivos.
|
KR20100007956A
(ko)
|
2007-05-03 |
2010-01-22 |
화이자 리미티드 |
나트륨 채널 조절제로서의 2-피리딘 카복스아마이드 유도체
|
CL2008001647A1
(es)
|
2007-06-08 |
2008-10-10 |
Syngenta Participations Ag |
Compuestos derivados de feniletil-amida de acido-1h-pirazol-4-carboxilico; compuestos derivados de (feniletil)amina; metodo para controlar o prevenir la infestacion de plantas por parte de microorganismos fitopatogenos; y composicion para el control
|
PE20090837A1
(es)
|
2007-07-02 |
2009-07-24 |
Boehringer Ingelheim Int |
Nuevos compuestos quimicos
|
EP2175728B1
(de)
*
|
2007-07-13 |
2014-09-10 |
Icagen, Inc. |
Natriumkanalhemmer
|
UA105758C2
(uk)
|
2007-07-19 |
2014-06-25 |
Х. Луннбек А/С |
5-членні гетероциклічні аміди та споріднені сполуки
|
US7977358B2
(en)
|
2007-07-26 |
2011-07-12 |
Hoffmann-La Roche Inc. |
Pyrazol derivatives
|
CA2701766A1
(en)
|
2007-10-11 |
2009-04-16 |
Vertex Pharmaceuticals Incorporated |
Amides useful as inhibitors of voltage-gated sodium channels
|
AU2008310663A1
(en)
|
2007-10-11 |
2009-04-16 |
Vertex Pharmaceuticals Incorporated |
Aryl amides useful as inhibitors of voltage-gated sodium channels
|
US8519137B2
(en)
|
2007-10-11 |
2013-08-27 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
|
JP5492092B2
(ja)
|
2007-11-07 |
2014-05-14 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Cb2受容体を調節する化合物
|
EP2241567A4
(de)
|
2008-02-13 |
2011-11-09 |
Eisai R&D Man Co Ltd |
Bicycloamin-derivat
|
DE102008015033A1
(de)
|
2008-03-17 |
2009-09-24 |
Aicuris Gmbh & Co. Kg |
Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
|
DE102008015032A1
(de)
|
2008-03-17 |
2009-09-24 |
Aicuris Gmbh & Co. Kg |
Substituierte Pyrazolamide und ihre Verwendung
|
US9212155B2
(en)
|
2008-03-19 |
2015-12-15 |
Aurimmed Pharma, Inc. |
Compounds advantageous in the treatment of central nervous system diseases and disorders
|
US10793515B2
(en)
|
2008-03-19 |
2020-10-06 |
Aurimmed Pharma, Inc. |
Compounds advantageous in the treatment of central nervous system diseases and disorders
|
US9206143B2
(en)
|
2008-03-19 |
2015-12-08 |
Aurimmed Pharma, Inc. |
Compounds advantageous in the treatment of central nervous system diseases and disorders
|
US20090281089A1
(en)
*
|
2008-04-11 |
2009-11-12 |
Genentech, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
WO2009134666A1
(en)
*
|
2008-04-29 |
2009-11-05 |
Boehringer Ingelheim International Gmbh |
Indazole compounds as ccr1 receptor antagonists
|
CA2722811C
(en)
*
|
2008-05-06 |
2016-07-05 |
Boehringer Ingelheim International Gmbh |
Pyrazole compounds as ccr1 antagonists
|
GEP20135957B
(en)
|
2008-06-19 |
2013-11-11 |
Takeda Pharmaceuticals Co |
Heterocyclic compound and usage thereof
|
JP5749162B2
(ja)
|
2008-07-10 |
2015-07-15 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Cb2受容体を調節するスルホン化合物
|
BRPI0919172A2
(pt)
*
|
2008-09-25 |
2015-12-15 |
Boehringer Ingelheim Int |
compostos os quais modulam seletivamente o receptor de cb2
|
AU2009296839A1
(en)
*
|
2008-09-26 |
2010-04-01 |
Boehringer Ingelheim International Gmbh |
Azaindazole compounds as CCR1 receptor antagonists
|
JP5603869B2
(ja)
|
2008-09-29 |
2014-10-08 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規化合物
|
US8101647B2
(en)
|
2008-10-17 |
2012-01-24 |
Xenon Pharmaceuticals Inc. |
Spiro-oxindole compounds and their use as therapeutic agents
|
EP2942350A1
(de)
|
2008-10-17 |
2015-11-11 |
Xenon Pharmaceuticals Inc. |
Spirooxindol-verbindungen und deren verwendungen als therapeutika
|
DE102008062878A1
(de)
|
2008-12-17 |
2010-06-24 |
Aicuris Gmbh & Co. Kg |
Substituierte Furancarboxamide und ihre Verwendung
|
DE102008062863A1
(de)
|
2008-12-17 |
2010-06-24 |
Aicuris Gmbh & Co. Kg |
Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
|
US8609696B2
(en)
|
2008-12-18 |
2013-12-17 |
Boehringer Ingelheim International Gmbh |
Serotonin 5-HT2B receptor inhibitors
|
US20110269788A1
(en)
|
2008-12-29 |
2011-11-03 |
Xenon Pharmaceuticals Inc. |
Spiro-oxindole-derivatives as sodium channel blockers
|
US9101616B2
(en)
|
2009-05-29 |
2015-08-11 |
Raqualia Pharma Inc. |
Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
|
US8299103B2
(en)
|
2009-06-15 |
2012-10-30 |
Boehringer Ingelheim International Gmbh |
Compounds which selectively modulate the CB2 receptor
|
EP2443107B1
(de)
|
2009-06-16 |
2018-08-08 |
Boehringer Ingelheim International GmbH |
Azetidin 2 -carboxamidderivate als cb2-rezeptormodulatoren
|
AR077252A1
(es)
|
2009-06-29 |
2011-08-10 |
Xenon Pharmaceuticals Inc |
Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
|
DE102009036604A1
(de)
|
2009-07-30 |
2011-02-03 |
Aicuris Gmbh & Co. Kg |
Substituierte Bis-Arylpyrazolamide mit terminaler primärer Amidfunktionalisierung und ihre Verwendung
|
WO2011037795A1
(en)
|
2009-09-22 |
2011-03-31 |
Boehringer Ingelheim International Gmbh |
Compounds which selectively modulate the cb2 receptor
|
RU2015103694A
(ru)
|
2009-10-14 |
2015-06-27 |
Ксенон Фармасьютикалз Инк. |
Способы синтеза спиро-оксиндольных соединений
|
NZ599132A
(en)
|
2009-10-21 |
2014-05-30 |
Boehringer Ingelheim Int |
Indazole and pyrazolopyridine compounds as ccr1 receptor antagonists
|
EP2493875B1
(de)
|
2009-10-27 |
2014-08-06 |
Boehringer Ingelheim International GmbH |
Iheterozyklische verbindungen als ccr1-rezeptorantagonisten
|
CN102596908A
(zh)
*
|
2009-12-08 |
2012-07-18 |
贝林格尔.英格海姆国际有限公司 |
用于制备取代的吲唑和氮杂吲唑化合物的中间体的合成方法
|
WO2011088015A1
(en)
|
2010-01-15 |
2011-07-21 |
Boehringer Ingelheim International Gmbh |
Compounds which modulate the cb2 receptor
|
PE20121699A1
(es)
|
2010-02-26 |
2012-12-22 |
Xenon Pharmaceuticals Inc |
Composiciones farmaceuticas del compuesto espiro-oxindol para administracion topica
|
US8329735B2
(en)
|
2010-03-05 |
2012-12-11 |
Boehringer Ingelheim International Gmbh |
Tetrazole compounds which selectively modulate the CB2 receptor
|
WO2011117382A1
(en)
|
2010-03-26 |
2011-09-29 |
Boehringer Ingelheim International Gmbh |
Pyridyltriazoles
|
EP2552905B1
(de)
|
2010-03-26 |
2016-10-05 |
Boehringer Ingelheim International GmbH |
Inhibitoren der B-Raf Kinase
|
EP2563787B1
(de)
|
2010-04-30 |
2014-11-26 |
Boehringer Ingelheim International GmbH |
Azaindazolamidverbindungen als ccr1-rezeptor-antagonisten
|
EP2595959B1
(de)
|
2010-07-22 |
2015-11-04 |
Boehringer Ingelheim International GmbH |
Sulfonylverbindungen zur modulierung des cb2-rezeptors
|
KR101458006B1
(ko)
*
|
2010-10-18 |
2014-11-04 |
라퀄리아 파마 인코포레이티드 |
Ttx-s 차단제로서의 아릴아미드 유도체
|
EP2630127A1
(de)
|
2010-10-21 |
2013-08-28 |
Glaxo Group Limited |
Pyrazolverbindungen, gegen allergie-, entzündungs- und immunerkrankungen
|
ES2532213T3
(es)
|
2010-10-21 |
2015-03-25 |
Glaxo Group Limited |
Compuestos de pirazol que actúan contra afecciones alérgicas, inmunitarias e inflamatorias
|
WO2012061926A1
(en)
*
|
2010-11-08 |
2012-05-18 |
Zalicus Pharmaceuticals Ltd. |
Bisarylsulfone and dialkylarylsulfone compounds as calcium channel blockers
|
AR083987A1
(es)
|
2010-12-01 |
2013-04-10 |
Bayer Cropscience Ag |
Amidas de acido pirazolcarboxilico utiles para la reduccion de la contaminacion de micotoxina en las plantas
|
US8710055B2
(en)
|
2010-12-21 |
2014-04-29 |
Boehringer Ingelheim International Gmbh |
Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
|
EP2655371B1
(de)
|
2010-12-23 |
2015-02-25 |
Boehringer Ingelheim International GmbH |
Pyrazolopiperidinverbindungen als ccr1-rezeptorantagonisten
|
BR112013029201B1
(pt)
|
2011-05-13 |
2022-08-09 |
Array Biopharma Inc |
Compostos de pirrolidinil ureia e pirrolidinil tioureia, seu processo de preparação, seu uso e composições farmacêuticas
|
WO2012177263A1
(en)
|
2011-06-24 |
2012-12-27 |
Intra-Cellular Therapies, Inc. |
Compounds and methods of prophylaxis and treatment regarding nictonic receptor antagonists
|
DE102011055815A1
(de)
|
2011-11-29 |
2013-05-29 |
Aicuris Gmbh & Co. Kg |
Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung
|
AU2013205306B2
(en)
|
2012-03-16 |
2015-09-17 |
Axikin Pharmaceuticals, Inc. |
3,5-diaminopyrazole kinase inhibitors
|
DK2838900T3
(da)
*
|
2012-04-17 |
2019-10-14 |
Gilead Sciences Inc |
Forbindelser og fremgangsmåder til antiviral behandling
|
BR112014026399B1
(pt)
*
|
2012-04-25 |
2022-11-01 |
Raqualia Pharma Inc |
Composto de fórmula (ii), composição farmacêutica, uso e processo para preparar uma composição farmacêutica
|
DE102012016908A1
(de)
|
2012-08-17 |
2014-02-20 |
Aicuris Gmbh & Co. Kg |
Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung
|
US10092574B2
(en)
|
2012-09-26 |
2018-10-09 |
Valorisation-Recherche, Limited Partnership |
Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof
|
CN103772284B
(zh)
*
|
2012-10-23 |
2015-08-12 |
沈阳感光化工研究院 |
一种4,5-二氨基-1-(2-羟乙基)吡唑硫酸盐的制备方法
|
CN102993097A
(zh)
*
|
2012-11-09 |
2013-03-27 |
贵州大学 |
吡唑酰胺类化合物及其应用
|
RU2664541C2
(ru)
|
2012-11-13 |
2018-08-20 |
Эррэй Биофарма Инк. |
Бициклические соединения мочевины, тиомочевины, гуанидина и цианогуанидина, пригодные для лечения боли
|
US9546156B2
(en)
|
2012-11-13 |
2017-01-17 |
Array Biopharma Inc. |
N-bicyclic aryl,N'-pyrazolyl urea, thiourea, guanidine cyanoguanidine compounds as TrkA kinase inhibitors
|
WO2014078325A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
US9969694B2
(en)
|
2012-11-13 |
2018-05-15 |
Array Biopharma Inc. |
N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
US9790178B2
(en)
|
2012-11-13 |
2017-10-17 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
WO2014078417A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
US9822118B2
(en)
|
2012-11-13 |
2017-11-21 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
UA116455C2
(uk)
|
2012-11-13 |
2018-03-26 |
Еррей Біофарма Інк. |
Сполуки n-піролідинілсечовини, n'-піразолілсечовини, тіосечовини, гуанідину та ціаногуанідину як інгібітори кінази trka
|
US9828360B2
(en)
|
2012-11-13 |
2017-11-28 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
WO2014078322A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
EP2943196A1
(de)
|
2013-01-10 |
2015-11-18 |
Grünenthal GmbH |
Pyrazolylbasierte carboxamide i als crac-kanal-hemmer
|
MX2015008912A
(es)
|
2013-01-10 |
2015-10-22 |
Gruenenthal Gmbh |
Carboxamidas basadas en pirazolilo ii como inhibidores del canal de calcio activado por liberacion de calcio (crac).
|
EP2803668A1
(de)
|
2013-05-17 |
2014-11-19 |
Boehringer Ingelheim International Gmbh |
Neuartige (Cyano-dimethyl-methyl)-isoxazole und -[1,3,4]-thiadiazole
|
TWI636047B
(zh)
|
2013-08-14 |
2018-09-21 |
英商卡爾維斯塔製藥有限公司 |
雜環衍生物
|
NZ631142A
(en)
|
2013-09-18 |
2016-03-31 |
Axikin Pharmaceuticals Inc |
Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
|
EP3049393A4
(de)
*
|
2013-09-25 |
2017-06-21 |
Valorisation-Recherche, Limited Partnership |
Inhibitoren von mit polynukleotidwiederholungen assoziierten rna-foci und verwendungen davon
|
RS59286B1
(sr)
|
2014-05-15 |
2019-10-31 |
Array Biopharma Inc |
1-((3s,4r)-4-(3-fluorofenil)-1-(2-metoksietil)pirolidin-3-il)-3-(4-metil-3-(2-metilpirimidin-5-il)-1-fenil-1h-pirazol-5-il)urea kao inhibitor trka kinaze
|
PT3152199T
(pt)
|
2014-06-03 |
2018-11-26 |
Idorsia Pharmaceuticals Ltd |
Compostos de pirazol e a sua utilização como bloqueadores de canais de cálcio do tipo t
|
EP3193609A4
(de)
*
|
2014-09-10 |
2018-02-28 |
Epizyme, Inc. |
Substituierte pyrrolidin-carboxamid-verbindungen
|
CN107074822B
(zh)
|
2014-09-15 |
2020-01-03 |
爱杜西亚药品有限公司 |
作为t型钙通道阻断剂的三唑化合物
|
CN104402819B
(zh)
*
|
2014-09-22 |
2016-08-24 |
安徽农业大学 |
一类双吡唑酰胺衍生物的制备及其在治理水稻黑条矮缩病中的应用
|
GB201421083D0
(en)
|
2014-11-27 |
2015-01-14 |
Kalvista Pharmaceuticals Ltd |
Enzyme inhibitors
|
GB201421085D0
(en)
|
2014-11-27 |
2015-01-14 |
Kalvista Pharmaceuticals Ltd |
New enzyme inhibitors
|
AU2015369690B2
(en)
|
2014-12-23 |
2019-01-17 |
SMA Therapeutics Inc. |
3,5-diaminopyrazole kinase inhibitors
|
AR103636A1
(es)
|
2015-02-05 |
2017-05-24 |
Teva Pharmaceuticals Int Gmbh |
Métodos de tratamiento de neuralgia postherpética con una formulación tópica de un compuesto de espiro-oxindol
|
WO2016202758A1
(en)
|
2015-06-18 |
2016-12-22 |
Bayer Pharma Aktiengesellschaft |
Substituted 2-(1h-pyrazol-1-yl)-1h-benzimidazole compounds
|
WO2016202756A1
(en)
|
2015-06-18 |
2016-12-22 |
Bayer Pharma Aktiengesellschaft |
Substituted 2-(1h-pyrazol-1-yl)-1h-benzimidazole compounds
|
WO2016202935A1
(en)
|
2015-06-19 |
2016-12-22 |
Bayer Pharma Aktiengesellschaft |
Glucose transport inhibitors
|
WO2017059191A1
(en)
*
|
2015-09-30 |
2017-04-06 |
Quartet Medicine, Inc. |
Heteroaryl derivatives as sepiapterin reductase inhibitors
|
WO2017063966A1
(en)
|
2015-10-13 |
2017-04-20 |
Bayer Pharma Aktiengesellschaft |
Substituted 2-(1h-pyrazol-1-yl)-benzothiazole compounds
|
AU2016370554B2
(en)
|
2015-12-18 |
2018-11-29 |
Merck Sharp & Dohme Corp. |
Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels
|
US10882841B2
(en)
*
|
2016-03-01 |
2021-01-05 |
University Of Maryland, Baltimore |
Wnt signaling pathway inhibitors for treatments of disease
|
RS60600B1
(sr)
|
2016-05-31 |
2020-08-31 |
Kalvista Pharmaceuticals Ltd |
Derivati pirazola kao inhibitori kalikreina plazme
|
GB201609603D0
(en)
|
2016-06-01 |
2016-07-13 |
Kalvista Pharmaceuticals Ltd |
Polymorphs of N-[(6-cyano-2-fluoro-3-methoxyphenyl)Methyl]-3-(methoxymethyl)-1-({4-[(2-ox opyridin-1-YL)Methyl]phenyl}methyl)pyrazole-4-carboxamide
|
GB201609607D0
(en)
|
2016-06-01 |
2016-07-13 |
Kalvista Pharmaceuticals Ltd |
Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts
|
MX2019007030A
(es)
|
2016-12-15 |
2020-01-15 |
Univ California |
Composiciones y metodos para el tratamiento del cancer.
|
PT3554490T
(pt)
|
2016-12-16 |
2022-03-17 |
Idorsia Pharmaceuticals Ltd |
Combinação farmacêutica compreendendo um bloqueador de canais de cálcio de tipo t
|
TWI795381B
(zh)
|
2016-12-21 |
2023-03-11 |
比利時商健生藥品公司 |
作為malt1抑制劑之吡唑衍生物
|
CN110225781B
(zh)
*
|
2017-01-09 |
2022-05-17 |
辉诺生物医药科技(杭州)有限公司 |
噻唑衍生物及其应用
|
CA3050348A1
(en)
|
2017-02-06 |
2018-08-09 |
Idorsia Pharmaceuticals Ltd |
A novel process for the synthesis of 1-aryl-1-trifluoromethylcyclopropanes
|
US11491150B2
(en)
|
2017-05-22 |
2022-11-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
RU2020121151A
(ru)
|
2017-11-29 |
2021-12-29 |
Калвиста Фармасьютикалз Лимитед |
Дозированные формы, содержащие ингибитор плазменного калликреина
|
GB201719881D0
(en)
|
2017-11-29 |
2018-01-10 |
Kalvista Pharmaceuticals Ltd |
Solid forms of plasma kallikrein inhibitor and salts thereof
|
EA202190055A1
(ru)
|
2018-06-18 |
2021-04-23 |
Янссен Фармацевтика Нв |
Производные пиразола в качестве ингибиторов malt1
|
AU2019289223B2
(en)
|
2018-06-18 |
2023-09-21 |
Janssen Pharmaceutica Nv |
Pyrazole derivatives as MALT1 inhibitors
|
EP3891157A4
(de)
|
2018-12-05 |
2022-08-31 |
Merck Sharp & Dohme Corp. |
4-amino- oder 4-alkoxysubstituierte arylsulfonamidverbindungen mit selektiver aktivität in spannungsgesteuerten natriumkanälen
|
WO2021028645A1
(en)
|
2019-08-09 |
2021-02-18 |
Kalvista Pharmaceuticals Limited |
Plasma kallikrein inhibitors
|
CN114044754A
(zh)
*
|
2021-11-23 |
2022-02-15 |
贵州大学 |
一类5-三氟甲基-4-吡唑衍生物的制备方法及其在抑制肿瘤细胞上的应用
|